POLK and central nervous system cancer: According to the Kaplan‐Meier analysis and log‐rank tests, we identified no significant associations between POLK rs3213801 polymorphism and prognosis of glioma patients based on OS and PFS (OS: P = .36; PFS: P = .25) (Figure 1).